Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Mar;137(1):103-110.
doi: 10.1007/s11060-017-2701-8. Epub 2017 Dec 4.

Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis

Cassie Kline  1   2 , Erin Felton  3 , I Elaine Allen  4 , Peggy Tahir  5 , Sabine Mueller  6   3   7
Affiliations
Meta-Analysis

Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis

Cassie Kline et al. J Neurooncol. 2018 Mar.

Abstract

Recurrent pediatric high-grade glioma is a leading cause of cancer-related death in children. We report results of a systematic review and meta-analysis investigating survival outcome in pediatric patients with recurrent high-grade glioma over the last 20 years. MEDLINE/PubMed, EMBASE, Web of Science and Cochrane Review databases were searched for relevant studies reporting on survival outcomes for pediatric patients with recurrent high-grade glioma treated between 1996 and 2016. Progression-free survival (PFS) and overall survival (OS) were calculated cumulatively over all studies, by therapy subgroup, and by decade of treatment. Random effects models were used to control for heterogeneity as measured by the I2 statistic. A total of 17 studies across 4 treatment strategies were included. Eleven investigated traditional chemotherapy, 1 investigated targeted therapy, 3 investigated immunotherapy, and 2 investigated radiotherapy. A total of 129 patients were included with a median age of 10.0 years. Cumulative PFS was 3.5 months (95% CI 2.1-5.0). Cumulative OS was 5.6 months (95% CI 3.9-7.3). OS was 4.0 months (95% CI 1.9-6.1) using traditional chemotherapy, 9.3 months using targeted therapies (95% CI 5.4-13), 6.9 months using immunotherapy (95% CI 2.1-12), and 14 months using reirradiation (95% CI 2.8-25). OS between 1996 and 2006 was 4.2 months (95% CI 2.1-6.2) compared to 8.5 months (95% CI 5.6-11) after 2006. Pediatric patients with recurrent high-grade glioma suffer from poor PFS and OS, regardless of therapy. There may be a trend towards improved OS in the last decade.

Keywords: Outcomes; Pediatric high-grade glioma; Recurrence; Survival.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: No contributing authors have any conflict of interest to declare.

Figures

Fig 1
Fig 1
Study inclusion/exclusion flowchart
Fig 2
Fig 2
Forest plot representing PFS across all studies
Fig 3
Fig 3
Forest plot representing OS across all studies
Fig 4
Fig 4
Forest plot representing OS by therapy
Fig 5
Fig 5
Forest plot representing OS by decade
See this image and copyright information in PMC

References

    1. Cage TA, Mueller S, Haas-Kogan D, Gupta N. High-grade gliomas in children. Neurosurg Clin N Am. 2012;23:515–523. doi: 10.1016/j.nec.2012.04.007. - DOI - PubMed
    1. Broniscer A, Gajjar A. Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. The oncologist. 2004;9:197–206. - PubMed
    1. Gottardo NG, Gajjar A. Chemotherapy for malignant brain tumors of childhood. Journal of child neurology. 2008;23:1149–1159. doi: 10.1177/0883073808321765. - DOI - PMC - PubMed
    1. Braunstein S, Raleigh D, Bindra R, Mueller S, Haas-Kogan D. Pediatric high-grade glioma: current molecular landscape and therapeutic approaches. Journal of neuro-oncology. 2017 doi: 10.1007/s11060-017-2393-0. - DOI - PubMed
    1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1–34. doi: 10.1016/j.jclinepi.2009.06.006. - DOI - PubMed

LinkOut - more resources